Clinical trials
Completed Carcinoma, Renal Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
910 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 27 |
| 2001 | 20 |
| 2002 | 21 |
| 2003 | 23 |
| 2004 | 42 |
| 2005 | 38 |
| 2006 | 52 |
| 2007 | 56 |
| 2008 | 51 |
| 2009 | 41 |
| 2010 | 42 |
| 2011 | 41 |
| 2012 | 40 |
| 2013 | 26 |
| 2014 | 33 |
| 2015 | 36 |
| 2016 | 60 |
| 2017 | 32 |
| 2018 | 40 |
| 2019 | 40 |
| 2020 | 34 |
| 2021 | 24 |
| 2022 | 20 |
| 2023 | 16 |
| 2024 | 6 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 910 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 69 |
| Pfizer | 52 |
| Novartis Pharmaceuticals | 26 |
| Bayer | 22 |
| Bristol-Myers Squibb | 21 |
| Memorial Sloan Kettering Cancer Center | 21 |
| GlaxoSmithKline | 19 |
| M.D. Anderson Cancer Center | 17 |
| Case Comprehensive Cancer Center | 13 |
| Radboud University Medical Center | 12 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 910 |
| Kidney Neoplasms | 249 |
| Melanoma | 122 |
| Carcinoma, Non-Small-Cell Lung | 117 |
| Neoplasms | 82 |
| Breast Neoplasms | 76 |
| Neoplasm Metastasis | 66 |
| Urinary Bladder Neoplasms | 63 |
| Carcinoma, Hepatocellular | 59 |
| Stomach Neoplasms | 56 |
Trials
Showing 1 to 25 of 910. Each trial links to its page on Pharma Observatory.
810 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.